Cargando…
Arthritis Interception in Patients with Psoriasis Treated with Guselkumab
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776915/ https://www.ncbi.nlm.nih.gov/pubmed/34837168 http://dx.doi.org/10.1007/s13555-021-00650-5 |
_version_ | 1784636941657964544 |
---|---|
author | Zabotti, Alen Giovannini, Ivan McGonagle, Dennis De Vita, Salvatore Stinco, Giuseppe Errichetti, Enzo |
author_facet | Zabotti, Alen Giovannini, Ivan McGonagle, Dennis De Vita, Salvatore Stinco, Giuseppe Errichetti, Enzo |
author_sort | Zabotti, Alen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8776915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-87769152022-02-02 Arthritis Interception in Patients with Psoriasis Treated with Guselkumab Zabotti, Alen Giovannini, Ivan McGonagle, Dennis De Vita, Salvatore Stinco, Giuseppe Errichetti, Enzo Dermatol Ther (Heidelb) Commentary Springer Healthcare 2021-11-27 /pmc/articles/PMC8776915/ /pubmed/34837168 http://dx.doi.org/10.1007/s13555-021-00650-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Commentary Zabotti, Alen Giovannini, Ivan McGonagle, Dennis De Vita, Salvatore Stinco, Giuseppe Errichetti, Enzo Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title | Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title_full | Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title_fullStr | Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title_full_unstemmed | Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title_short | Arthritis Interception in Patients with Psoriasis Treated with Guselkumab |
title_sort | arthritis interception in patients with psoriasis treated with guselkumab |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776915/ https://www.ncbi.nlm.nih.gov/pubmed/34837168 http://dx.doi.org/10.1007/s13555-021-00650-5 |
work_keys_str_mv | AT zabottialen arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab AT giovanniniivan arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab AT mcgonagledennis arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab AT devitasalvatore arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab AT stincogiuseppe arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab AT errichettienzo arthritisinterceptioninpatientswithpsoriasistreatedwithguselkumab |